PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-48.13%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-69.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-116.77%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-116.77%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-123.79%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-118.55%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-118.55%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
28.12%
Slight or no buybacks while MTDR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
27.89%
Diluted share change of 27.89% while MTDR is zero. Bruce Berkowitz might see a minor difference that could widen over time.
68.11%
Dividend growth of 68.11% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-5.37%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-198.57%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-83.53%
Negative 10Y revenue/share CAGR while MTDR stands at 616.22%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-60.40%
Negative 5Y CAGR while MTDR stands at 36.65%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
13.09%
3Y revenue/share CAGR under 50% of MTDR's 197.38%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-82.25%
Negative 10Y OCF/share CAGR while MTDR stands at 146.39%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-65.97%
Negative 5Y OCF/share CAGR while MTDR is at 7.81%. Joel Greenblatt would question the firm’s operational model or cost structure.
132.32%
3Y OCF/share CAGR similar to MTDR's 143.65%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
-115.65%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-228.12%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
55.43%
3Y net income/share CAGR 50-75% of MTDR's 88.11%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
-72.76%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
20.07%
Below 50% of MTDR's 67.63%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
29.76%
Below 50% of MTDR's 143.54%. Michael Burry suspects a serious short-term disadvantage in building book value.
-94.27%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-66.69%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
48.51%
3Y dividend/share CAGR of 48.51% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
96.71%
AR growth well above MTDR's 3.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
41.32%
Asset growth above 1.5x MTDR's 3.70%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.58%
BV/share growth above 1.5x MTDR's 2.75%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
41.28%
Debt growth far above MTDR's 7.74%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
122.44%
SG&A growth well above MTDR's 34.79%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.